Supernus Pharmaceuticals financial statements

Name: Quantus Signal — KR/US technical signal dataset
License: https://www.quantus.kr/signal/terms

슈퍼누스 파머슈티컬스NASDAQ:SUPN · Nasdaq · Healthcare · sector #17

$42.83+0.16%

2026-10-06 close

Supernus Pharmaceuticals's published financial data is dated 2026-10-04. 2024 revenue was $662M. 2024 operating profit was $82M.

Reported results

Quantus Signal · live data · not investment advice · Privacy Policy